Ennaid Therapeutics | Black Woman Scientist Files Patent For Coronavirus Treatment
19546
post-template-default,single,single-post,postid-19546,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-6.2.0,vc_non_responsive

Black Woman Scientist Files Patent For Coronavirus Treatment

01 May Black Woman Scientist Files Patent For Coronavirus Treatment

Darnisha Harrison, founder and CEO of Ennaid Therapeutics, says that scientists working for her company have found a drug that is showing promise in laboratories at blocking the continued spread of COVID-19. Based in Atlanta, Georgia, her company uses its artificial intelligence (AI)-based drug discovery platforms to develop anti-viral drugs.

Both BET News and WBRZ-TVan ABC News affiliate in Baton Rouge, have confirmed that Harrison, who graduated from Louisiana State University, has already filed a patent after discovering a drug that shows strong scientific evidence of blocking two proteins that cause COVID-19 from invading healthy host cells and replicating.

The drug is called ENU200, a repurposed, patent-pending, orally deliverable antiviral drug that was previously approved by the U.S. Food and Drug Administration (FDA) for a different indication.

To read the rest of the article HERE

Tags:
No Comments

Post A Comment